Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP7 | P09237 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | MMP14 | P50281 | 2/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575589 | 0.87 | CA2 (0.52) | CA2CA9CA12CA1MMP2 | |
| SCHEMBL8887826 | 0.87 | STS (0.55) | CA2CA9CA12CA1ALDH1A1 | |
| SCHEMBL3838977 | 0.80 | CA2 (0.58) | CA2CA9CA12CA1MMP2 | |
| SCHEMBL779427 | 0.80 | SOS1 (0.48) | SOS1CA2CA9CA12CA1 | |
| SCHEMBL3710207 | 0.80 | PTGS2 (0.57) | CA2CA9CA12CA1ALDH1A1 | |
| SCHEMBL3710205 | 0.80 | PTGS2 (0.57) | CA2CA9CA12CA1ALDH1A1 | |
| SCHEMBL31634374 | 0.78 | SOS1 (0.47) | SOS1CA2CA9CA12CA1 | |
| SCHEMBL6941035 | 0.78 | CA1 (0.64) | CA2CA9CA12CA1MMP2 | |
| SCHEMBL168170 | 0.78 | CA2 (0.64) | CA2CA9CA12CA1MMP2 | |
| SCHEMBL9529411 | 0.78 | SOS1 (0.47) | SOS1CA2CA9CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8512897-B2 | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES, LTD. (JP) | 2013-08-20 | — | — | US | claimed |
| CN-101842349-B | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES | 2013-07-17 | — | — | CN | claimed |
| US-6737550-B2 | LITHIUM SALT OF 4- FLUOROPHENYL METHYL SULFONE AS THE CHEMICAL INTERMEDIATE; DRUG WITH ANTIANDROGEN ACTIVITY | BIOGAL GRYOGYSZERGYAR RT. (HU) | 2004-05-18 | — | — | US | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-11897857-B2 | Isotopically-stabilized tetronimide compounds | MIDWESTERN UNIVERSITY (US) | 2024-02-13 | — | — | US | disclosed |
| CN-111196781-B | Improved method for preparing pentafluoride | 湖南中南制药有限责任公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-20210094927-A1 | ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS | MIDWESTERN UNIVERSITY | 2021-04-01 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-08-06 | — | — | US | disclosed |
| CN-1871212-A | Process for producing triarylsulfonium salt | WAKO PURE CHEM IND LTD (JP) | 2006-11-29 | — | — | CN | disclosed |
| CN-1854133-A | Heterocycle-bearing onium salts | WAKO PURE CHEM IND LTD (JP) | 2006-11-01 | — | — | CN | disclosed |
| CN-1678574-A | Process for producing aminoalkylsulfonic acid and method of salt exchange for salt thereof | WAKO PURE CHEM IND LTD (JP) | 2005-10-05 | — | — | CN | disclosed |
| CN-1622943-A | Heterocyclic onium salt | WAKO PURE CHEM IND LTD (JP) | 2005-06-01 | — | — | CN | disclosed |
| CN-1578766-A | Hybrid onium salt | WAKO PURE CHEM IND LTD (JP) | 2005-02-09 | — | — | CN | disclosed |
| EP-0648723-B1 | Diphenylacetylene compound, process for preparing the same and liquid crystal composition and element comprising the same | SUMITOMO CHEMICAL CO (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5658489-A | EXCELLENT ANISOTROPY OF REFRACTIVE INDEX; LOW VISCOSITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0648723-A1 | Diphenylacetylene compound, process for preparing the same and liquid crystal composition and element comprising the same | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1995-04-19 | — | — | EP | disclosed |
| CN-1091432-A | Can suppress the active peptide of hiv protease, its preparation with and medical use | SANKYO CO (JP) | 1994-08-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897857-B2 | Isotopically-stabilized tetronimide compounds | ASPH, BACE1, DNPEP | SOS1 1087/4885CA2 2174/4885CA9 2215/4885 |
| US-20210094927-A1 | ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS | ASPH, BACE1, DNPEP | SOS1 1087/4885CA2 2174/4885CA9 2215/4885 |
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | HCN2, PHOSPHO1, HCN1 | SOS1 4207/4885CA2 454/4885CA9 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.